Trio HealthLa Mirada, California, United States
Disclosure(s): Trio Health: Employee
505 - Real-World Use of Cabotegravir Long-Acting for Pre-Exposure Prophylaxis: Data from Trio Health Cohort
Saturday, October 19, 202410:45 AM – 11:00 AM US PT